Crossmark

Multivariate integrated predictive model for 1-year mortality risk prognosis in patients undergoing esophageal cancer resection: establishment and validation

Crossref DOI link: https://doi.org/10.1186/s12893-025-03478-4

Published Online: 2026-01-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kurexi, Adilai

Mijiti, Maimaiti

Yuan, Tingting

Zhang, Yaozhong

Wei, Fanrong

Yan, Rui
License Information

Text and Data Mining valid from 2026-01-21

Version of Record valid from 2026-02-13
More Information

Article History

Received: 17 November 2025

Accepted: 29 December 2025

First Online: 21 January 2026

Declarations

:

: This study was approved by the Ethics Committee of the Third Clinical Medical College (Affiliated Cancer Hospital) of Xinjiang Medical University (Ethics Approval No. K-2024258). Adhering to the Declaration of Helsinki, informed consent was waived due to the retrospective nature of the study and the full anonymization of all clinical data, which precluded identification of individual participants.Given the retrospective design and anonymized data collection, formal written informed consent from individual participants was not required and was therefore waived by the Ethics Committee of the Third Clinical Medical College (Affiliated Cancer Hospital) of Xinjiang Medical University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below